1st Edition
The Japanese Pharmaceutical Industry Its Evolution and Current Challenges
By Maki Umemura
Copyright 2011
208 Pages
18 B/W Illustrations
by
Routledge
208 Pages
18 B/W Illustrations
by
Routledge
208 Pages
18 B/W Illustrations
by
Routledge
Also available as eBook on:
This book explores why Japan, despite being a world leader in many high technology industries such as automobiles and consumer electronics, is only a minor player in the global pharmaceutical industry. Japan provides a huge market for pharmaceuticals as the second largest consumer of prescription drugs after the United States, and is a massive importer of prescription drugs, relying on... Read more
1. Introduction: Why didn’t Japan become a global leader in pharmaceuticals? 2. A historical overview of Japan’s pharmaceutical industry 3. Developing a modern industry: The antibiotics sector 4. What went wrong? The anticancer drug sector 5. Conclusion: Reconsidering Japan’s business in pharmaceuticals
Biography
Maki Umemura is a lecturer in Japanese studies at Cardiff Business School, Cardiff University, UK.
'The Japanese Pharmaceutical Industry is an ambitious, broad-ranging analysis of the postwar history of an industry whose eight per cent share of Japanese manufacturing understates its significance in terms of health and as a barometer for science-based innovation.' - Robert Kneller, University of Tokyo; Journal of Japanese Studies, 2013.
